Topic
PhRMA
23 published works
Big Molecule Watch
Court Dismisses PhRMA Lawsuit Challenging IRA
By Alexandra Lu
Today, the district court for the Western District of Texas granted the government’s motion to dismiss the lawsuit brought by PhRMA and other organizations challenging the Drug Price Negotiation Program…
Health Care Law Today
PhRMA Code Update Clarifies and Tightens Key Provisions Associated with Speaker Programs
Undoubtedly in response to OIG’s November 2020 Special Fraud Alert: Speaker Programs issued, on August 6, 2021, PhRMA issued a statement addressing an update to the PhRMA Code on Interactions…
Life Sciences Perspectives
PhRMA Issues Updates to Longstanding Code, Addresses OIG’s Speaker Program Guidance
By Matt Wetzel|Elizabeth Mulkey
PhRMA, the pharmaceutical manufacturer trade association, announced on Fri. August 6 that it has revised its longstanding Code on Interactions with Health Care Professionals. The revisions, which relate to the…
Health Care Law Today
HCP Conflicts of Interest: Virtual Informational Sessions – With Lunch – Supported by PhRMA During Declared Emergencies
On June 30, 2020, PhRMA released a Statement on Application of PhRMA Code Section 2 During Emergency Periods, which recognizes the difficulty in complying with the Code’s requirement that informative…
Health Industry Washington Watch
Speakers from WebMD, CMS, PhRMA, AdvaMed, AHCA, and More to Present at Reed Smith’s Dec. 4 Washington Health Care Conference
Reed Smith is hosting its 6th Annual Washington Health Care Conference on December 4, 2019 at The Almas Center in Washington, D.C., and is pleased to welcome another impressive line-up…
Life Sciences Legal Update
Hear from Speakers from WebMD, CMS, PhRMA, AdvaMed, AHCA and More at Dec. 4 Washington Health Care Conference
By Lisa Baird
Please join us for our 6th Annual Washington Health Care Conference, a program discussing the latest hot topics and anticipated trends impacting health care and life sciences organizations. This year’s…
BioSlice Blog
The new IFPMA Code of Practice
By Ian Dodds-Smith, Silvia Valverde, Keir Heinrich
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has recently published a new version of its Code of Practice that will come into force on January 1, 2019, updating…
Drug Pricing Policy Watch
PhRMA Mounts Legal Challenge to SB 17 in California
The recently enacted California drug price transparency law SB 17 is facing a legal challenge to its constitutionality in the form of a PhRMA lawsuit filed in the US District…
Drug Pricing Policy Watch
Trade Organizations Challenge Nevada’s Drug Price Transparency Law
We recently wrote about the newly enacted Nevada drug price transparency law here. The law requires manufacturers of prescription diabetes drugs to disclose certain drug cost information to the state…
Drug & Device Law
The Rule of Law is the Best Medicine, Part 2
Last week, we summarized PhRMA’s comments on the FDA’s proposed amendments to regulations regarding “intended uses.” PhRMA showed how the FDA’s insistence that it could read manufacturer’s minds about intended…